Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-002717·ARK Investment Management LLC
Schedule 13G ownership disclosure
CRISPR Therapeutics AG
Common Stock · CUSIP: H17182108
Event date: 2024-09-30
- Filing-level shares
- 7,498,625.00
- Percent of class
- 8.80%
- ARK Investment Management LLC
Shares: 7,498,625.00 · Class: 8.80%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-002717
- Form type
- SCHEDULE 13G/A
- Filer
- ARK Investment Management LLC
- CIK
- CIK 1697748
- Filed
- Jan 10, 2025
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership